Increasing evidence indicates that glutamate plays a role in Obsessive-Compulsive Disorder (OCD) symptoms. Ketamine, which acts on brain glutamate receptors, has shown remarkable therapeutic effects in OCD; however, patients reported side effects including transient dissociation. The glutamate receptor modulator rapastinel may reduce symptoms of OCD without the dissociative side effects reported by patients treated with ketamine.
Watch webinar recording:
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
Sign up for upcoming webinars.